Biosurgical Agents | Market Insights | Latin America (Supplemental) | 2021
Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.
This Medtech 360 Report provides high-level market metrics for biosurgical agents in Latin America, including country-level data for major countries and aggregate data for the rest of the Latin American region, across a 10-year period.
